The Society for Immunotherapy of Cancer’s Cancer Immunotherapy Winter School 2024

January 30 – February 2, 2024 | Austin, Texas and Virtual

The upcoming Cancer Immunotherapy Winter school is set to provide early-to-mid career scientists and clinicians with cutting-edge education and a transformative experience. Join us in Austin, Texas, or virtually for an unparalleled learning opportunity in the field of cancer immunotherapy.

Winter School is designed for cancer immunotherapy professionals working across various sector including academia, clinical practice, industry and government. With a faculty consisting of experts in the field, attendees will gain in-depth understanding of fundamental tumor immunology and cancer immunotherapy principles.

This program offers a comprehensive curriculum that covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experiences by selecting the educational path most relevant to their learning goals. Winter School immerses participants with emerging strategies on subjects like drug and biomarker technologies and their clinical application. Explore appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design.

In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees will expand their professional network, developing new relationships with faculty and other thought leaders in this intimate setting.

Learn more about the program.

Program Organizers

  • Organizer, Justin Eyquem, PhD, University of California – San Francisco
  • Organizer, Chrystal Paulos, PhD, Winship Cancer Institute at Emory University
  • Organizer, Daniel Powell Jr., PhD, University of Pennsylvania
  • Program Advisor, Christian Capitini, MD, University of Wisconsin-Madison
 

Program Objectives

Upon completion of the Cancer Immunotherapy Winter School, participants are able to:

  • Describe the core principles of tumor immunology and cancer immunotherapy.
  • Discuss recent advancements in drug and biomarker technologies and their clinical application.
  • Explain appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design.

CO-SPONSORS

TERMS OF USE & PRIVACY POLICY

 

Connect With Us: